Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Current Gene Therapy|February 20, 2007
Gene therapy in disorders of lipoprotein metabolismStefan F C Vaessen, Jaap Twisk, John J P Kastelein, et al.
Atherosclerosis|November 8, 2006
Adeno-associated virus LPL(S447X) gene therapy in LDL receptor knockout miceJaap Rip, Jeroen A Sierts, Stefan F C Vaessen, et al.
Biochimica Et Biophysica Acta|September 23, 2006
AAV1-LPL(S447X) gene therapy reduces hypertriglyceridemia in apoE2 knock in miceJaap Rip, Ko Willems van Dijk, Jeroen A Sierts, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2003
Transplantation of monocyte CC-chemokine receptor 2-deficient bone marrow into ApoE3-Leiden mice inhibits atherogenesisJian Guo, Miranda Van Eck, Jaap Twisk, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2006
Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in ratsJurgen Seppen, Conny Bakker, Berry de Jong, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2012
Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patientsAndré C Carpentier, Frédérique Frisch, Sébastien M Labbé, et al.
Circulation Research|June 28, 2003
Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymesPeter A C 't Hoen, Christian A C Van der Lans, Miranda Van Eck, et al.
Pageof 3